Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zangrillo

Showing results (301-310 of 373) with videos related to

Pageof 38
Sort By:
Kidney & Blood Pressure Research|February 14, 2022
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk StratificationCarlo Andrea Bravi, Walter Cazzaniga, Marco Simonini, et al.
Journal of Cardiothoracic and Vascular Anesthesia|March 8, 2021
Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 PatientsAlessandro Belletti, Diego Palumbo, Alberto Zangrillo, et al.
The Lancet. Rheumatology|March 3, 2021
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort studyGiulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, et al.
Annals of the Rheumatic Diseases|July 5, 2020
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort studyEmanuel Della-Torre, Corrado Campochiaro, Giulio Cavalli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 3, 2020
Inappropriate dose of nonvitamin-K antagonist oral anticoagulants: prevalence and impact on clinical outcome in patients with nonvalvular atrial fibrillationCosmo Godino, Francesca Bodega, Francesco Melillo, et al.
The American Journal of Cardiology|September 13, 2023
Baseline Characteristics and 3-Year Outcome of Nonvalvular Atrial Fibrillation Patients Treated with the Four Direct Oral Anticoagulants (DOACs)Giulia Nemola, Anita Russi, Gianmarco Cozzani, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 2, 2022
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical VentilationAlberto Zangrillo, Alessandro Belletti, Diego Palumbo, et al.
JAMA|April 7, 2020
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyGiacomo Grasselli, Alberto Zangrillo, Alberto Zanella, et al.
Minerva Medica|June 28, 2021
Safety and efficacy of direct oral anticoagulants (DOACs) in very elderly patients (≥85 years old) with non-valvular atrial fibrillationClaudia Rubino, Fabiana Blunda, Francesca Bodega, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2021
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort studyCaterina Conte, Antonio Esposito, Rebecca De Lorenzo, et al.
Pageof 38

Showing results (301-310 of 373) with videos related to

Sort By:
Pageof 38
Kidney & Blood Pressure Research|February 14, 2022
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk StratificationCarlo Andrea Bravi, Walter Cazzaniga, Marco Simonini, et al.
Journal of Cardiothoracic and Vascular Anesthesia|March 8, 2021
Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 PatientsAlessandro Belletti, Diego Palumbo, Alberto Zangrillo, et al.
The Lancet. Rheumatology|March 3, 2021
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort studyGiulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, et al.
Annals of the Rheumatic Diseases|July 5, 2020
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort studyEmanuel Della-Torre, Corrado Campochiaro, Giulio Cavalli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 3, 2020
Inappropriate dose of nonvitamin-K antagonist oral anticoagulants: prevalence and impact on clinical outcome in patients with nonvalvular atrial fibrillationCosmo Godino, Francesca Bodega, Francesco Melillo, et al.
The American Journal of Cardiology|September 13, 2023
Baseline Characteristics and 3-Year Outcome of Nonvalvular Atrial Fibrillation Patients Treated with the Four Direct Oral Anticoagulants (DOACs)Giulia Nemola, Anita Russi, Gianmarco Cozzani, et al.
Journal of Cardiothoracic and Vascular Anesthesia|January 2, 2022
One-Year Multidisciplinary Follow-Up of Patients With COVID-19 Requiring Invasive Mechanical VentilationAlberto Zangrillo, Alessandro Belletti, Diego Palumbo, et al.
JAMA|April 7, 2020
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyGiacomo Grasselli, Alberto Zangrillo, Alberto Zanella, et al.
Minerva Medica|June 28, 2021
Safety and efficacy of direct oral anticoagulants (DOACs) in very elderly patients (≥85 years old) with non-valvular atrial fibrillationClaudia Rubino, Fabiana Blunda, Francesca Bodega, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2021
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort studyCaterina Conte, Antonio Esposito, Rebecca De Lorenzo, et al.
Pageof 38